OBJECTIVE: Acute kidney injury frequently complicates septic shock and independently predicts mortality in this population. Clinical factors alone do not entirely account for differences in risk of acute kidney injury between patients. Genetic variants are likely to explain this differential susceptibility. To identify genetic variants linked to acute kidney injury susceptibility, we conducted a high-density genotyping association study in a large population of patients with septic shock. DESIGN: Retrospective study. SETTING: Tertiary academic medical center. PATIENTS: One thousand two hundred and sixty-four patients with septic shock were analyzed to elucidate clinical risk factors associated with the development of acute kidney injury. Among them, 887 Caucasian patients were randomly split into discovery and validation cohorts and genotyped using the Illumina Human-CVD BeadChip (Illumina, San Diego, CA). INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Six hundred and twenty-seven of the 1,264 patients with septic shock and 441 of the 887 patients with genotyping data developed acute kidney injury within the first 72 hrs of intensive care unit admission. Five single nucleotide polymorphisms were associated with acute kidney injury in both the discovery and validation cohorts. Two of these were in the BCL2 gene and both were associated with a decreased risk of acute kidney injury (rs8094315: odds ratio 0.61, p = .0002; rs12457893: odds ratio 0.67, p = .0002, both for combined data). Bcl-2 is involved in the apoptosis pathway, which has previously been implicated in acute kidney injury. Another single nucleotide polymorphism was in the SERPINA4 gene, whose protein product, kallistatin, has been linked to apoptosis in the kidney. CONCLUSIONS: Large-scale genotyping reveals two single nucleotide polymorphisms in the BCL2 gene and a single nucleotide polymorphism in the SERPINA4 gene associated with a decreased risk of developing acute kidney injury, supporting the putative role of apoptosis in the pathogenesis of acute kidney injury.
OBJECTIVE:Acute kidney injury frequently complicates septic shock and independently predicts mortality in this population. Clinical factors alone do not entirely account for differences in risk of acute kidney injury between patients. Genetic variants are likely to explain this differential susceptibility. To identify genetic variants linked to acute kidney injury susceptibility, we conducted a high-density genotyping association study in a large population of patients with septic shock. DESIGN: Retrospective study. SETTING: Tertiary academic medical center. PATIENTS: One thousand two hundred and sixty-four patients with septic shock were analyzed to elucidate clinical risk factors associated with the development of acute kidney injury. Among them, 887 Caucasian patients were randomly split into discovery and validation cohorts and genotyped using the Illumina Human-CVD BeadChip (Illumina, San Diego, CA). INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Six hundred and twenty-seven of the 1,264 patients with septic shock and 441 of the 887 patients with genotyping data developed acute kidney injury within the first 72 hrs of intensive care unit admission. Five single nucleotide polymorphisms were associated with acute kidney injury in both the discovery and validation cohorts. Two of these were in the BCL2 gene and both were associated with a decreased risk of acute kidney injury (rs8094315: odds ratio 0.61, p = .0002; rs12457893: odds ratio 0.67, p = .0002, both for combined data). Bcl-2 is involved in the apoptosis pathway, which has previously been implicated in acute kidney injury. Another single nucleotide polymorphism was in the SERPINA4 gene, whose protein product, kallistatin, has been linked to apoptosis in the kidney. CONCLUSIONS: Large-scale genotyping reveals two single nucleotide polymorphisms in the BCL2 gene and a single nucleotide polymorphism in the SERPINA4 gene associated with a decreased risk of developing acute kidney injury, supporting the putative role of apoptosis in the pathogenesis of acute kidney injury.
Authors: Glenn M Chertow; Elisabeth Burdick; Melissa Honour; Joseph V Bonventre; David W Bates Journal: J Am Soc Nephrol Date: 2005-09-21 Impact factor: 10.121
Authors: Ravindra L Mehta; John A Kellum; Sudhir V Shah; Bruce A Molitoris; Claudio Ronco; David G Warnock; Adeera Levin Journal: Crit Care Date: 2007 Impact factor: 9.097
Authors: Vincenzo Cantaluppi; Barbara Assenzio; Daniela Pasero; Giuseppe Mauriello Romanazzi; Alfonso Pacitti; Giacomo Lanfranco; Valeria Puntorieri; Erica L Martin; Luciana Mascia; Gianpaola Monti; Giampaolo Casella; Giuseppe Paolo Segoloni; Giovanni Camussi; V Marco Ranieri Journal: Intensive Care Med Date: 2008-05-08 Impact factor: 17.440
Authors: Morteza Bashash; Joseph M Connors; Randy D Gascoyne; Barbara Meissner; Johanna M Schuetz; Stephen Leach; Graham W Slack; Brian R Berry; Howard Hu; Laurie H Sehn; Angela R Brooks-Wilson; John J Spinelli Journal: Haematologica Date: 2017-02-02 Impact factor: 9.941
Authors: Anna Rautanen; Tara C Mills; Anthony C Gordon; Paula Hutton; Michael Steffens; Rosamond Nuamah; Jean-Daniel Chiche; Tom Parks; Stephen J Chapman; Emma E Davenport; Katherine S Elliott; Julian Bion; Peter Lichtner; Thomas Meitinger; Thomas F Wienker; Mark J Caulfield; Charles Mein; Frank Bloos; Ilona Bobek; Paolo Cotogni; Vladimir Sramek; Silver Sarapuu; Makbule Kobilay; V Marco Ranieri; Jordi Rello; Gonzalo Sirgo; Yoram G Weiss; Stefan Russwurm; E Marion Schneider; Konrad Reinhart; Paul A H Holloway; Julian C Knight; Chris S Garrard; James A Russell; Keith R Walley; Frank Stüber; Adrian V S Hill; Charles J Hinds Journal: Lancet Respir Med Date: 2014-12-18 Impact factor: 30.700